Introduction
Nuclear factor kappa B (NF-kB) is a redox-associated transcription factor (1) that is involved in the activation of survival pathways (2) (3) (4) . NF-kB protects against apoptosis (5) (6) (7) (8) and is constitutively elevated in many different types of cancer (9) (10) (11) (12) (13) . NF-kB enhances tumor progression (14, 15) , in part, through the activation of inducible nitric oxide synthase and cyclooxygenase-2 (16, 17) and the release of proliferative and anti-apoptotic cytokines (12, 18) . NF-kB can be activated through multiple mechanisms involving genotoxic stress (19) , the activation of cell surface receptors (20) (21) (22) (23) , the generation of exogenous and endogenous reactive oxygen species (ROS) (22, (24) (25) (26) (27) and increased cytosolic levels of Ca ++ (27) (28) (29) (30) (31) (32) (33) (34) (35) .
Persistent activation of NF-kB in the colon can lead to the production of pro-inflammatory molecules, resulting in colitis and, ultimately, colon cancer (7, (16) (17) (18) . The inflammatory diseases of the colon, Crohn's disease and ulcerative colitis, are associated with the constitutive activation of NF-kB in the pre-neoplastic colonic crypts and stroma (16, 17) . However, most cases of sporadic colon cancer are not associated with predisposing inflammatory conditions such as Crohn's disease and ulcerative colitis. From an epidemiologic standpoint, the consumption of a high-fat, low-fiber, low micronutrient Western-style diet is associated with increased colon cancer risk (36) (37) (38) (39) , which has been confirmed in an animal model in the absence of a carcinogen (40) . One major factor associated with a high-fat, low-fiber diet is the endogenous production of bile acids from cholesterol (41) . Primary conjugated bile acids are biotransformed by intestinal bacteria through a process of deconjugation and dehydroxylation to produce secondary, hydrophobic bile acids (42) , the most prominent of which is deoxycholate (DOC).
DOC has pleiotropic effects on colon cells including the induction of oxidative stress, DNA damage and apoptosis [see recent review from our group (43) ]. We were the first to show that DOC activates NF-kB in hepatocytes (44) , HCT-116 and HT-29 colon epithelial cells (45, 46) , which could be prevented by lazaroids (46) , potent inhibitors of lipid peroxidation. We also reported that persistent exposure of HCT-116 cells to increasing concentrations of DOC results in the selection for cells having constitutive activation of NF-kB, which is associated with the development of apoptosis resistance (6) . Apoptosis resistance is now considered to be an important condition that contributes to genomic instability and the initiation and progression of cancer (47) (48) (49) .
What is not known are the mechanisms by which DOC activates NF-kB in colon epithelial cells and whether natural antioxidants can reduce DOC-induced NF-kB activation. Also, it is not known if DOC can generate ROS within mitochondria as a possible pathway of stress-related NF-kB activation in colon epithelial cells. In non-colon cell types, it has been shown that NF-kB can be activated by ROSdependent and ROS-independent signaling pathways (1, 24, 50) . Since DOC is known to cause membrane perturbation (51-53), we explored, in the present study, the activation of ROS-generating plasma membrane-associated enzymes by DOC, in addition to other hypothesis-driven mechanisms based on our studies (6) and those of others. We found that DOC activates NF-kB through multiple mechanisms involving NAD(P)H oxidase, Na + /K + -ATPase, cytochrome P450, Ca ++ and the terminal mitochondrial respiratory complex IV. These NF-kB-activating pathways, induced by the dietary-related endogenous detergent DOC, provide mechanisms for promotion of colon cancer and identify possible new targets for chemoprevention. (50) and oxidative stress/DOC-induced apoptosis, as described previously (54) . Persistent exposure of these cells to increasing concentrations of DOC also results in the constitutive activation of NF-kB (6) . HCT-116 cells were maintained in DMEM supplemented with 10% heat-inactivated fetal calf serum (Omega Scientific, Tarzana, CA), 1% MEM non-essential amino acids, 100 mg/ml streptomycin, 100 U/ml penicillin and 3.44 mg/ml L-glutamine. HCT-116 cells, growing in log phase, were plated into 24-well Falcon flat-bottom polystyrene plates (Becton Dickinson). For all treatments, only cells in approximate mid-logarithmic growth phase were used, so that comparisons between treatment groups would be valid and reproducible (55) . Experiments were performed between passages 3 and 15, after dilution of the cells from stationary phase to 2 · 10 5 , and allowing cells to grow exponentially to 8 · 10 5 cells/ml. This density of exponentially growing cells placed the cells at 30-50% of their maximum stationary phase value. Media components were from Gibco BRL Life Technologies (Grand Island, NY). All experiments were repeated at least twice.
Materials and methods

Chemicals
Assessment of oxidative stress within mitochondria Mitochondrial stress within mitochondria was assessed using MitoSOXÔ Red, a highly selective fluorescent probe for the detection of ROS generated within mitochondria. All incubations with DOC were performed at 37 C in a CO 2 incubator, and the fluorescent signal emitted from the oxidized MitoSOXÔ Red reagent was detected using flow cytometry. HCT-116 cells were grown to mid-log phase, and dose-response curves were performed at 4 h incubation with varying concentrations of DOC (0.1-0.5 mM). The cells were then trypsinized and washed with fresh medium. MitoSOXÔ Red was added to the washed cells at a final concentration of 5 mM in culture media and incubated at 37 C for 10 min. The cells were then washed with PBS. Fluorescence intensity was analyzed using a BD FACScan flow cytometer with excitation at 488 nm and emission at 620 nm. A minimum of 10 000 events was collected. Results are presented as single-parameter histograms or scattergrams of cellular events versus fluorescence intensity. The experiment was repeated twice, each time in triplicate. The flow cytometry data were evaluated using WinMDI 2.8 software. Statistical evaluation was assessed on triplicate values for control (untreated) and treatment groups using Student's t-test. The difference in the mean values between control and treatment groups was considered to be statistically significant at the 95% probability level.
Assessment of mitochondrial membrane potential (MMP) by flow cytometry
The lipophilic, cationic dye, Mitotracker Red Ò (CMXRos) (Molecular Probes, Eugene, OR) was used to detect changes in level of MMP, as described previously (54, 56, 57) . Control (untreated) cells and cells incubated with varying concentrations of DOC (0.1-0.5 mM) for 4 h were trypsinized and added to fresh media. CMXRos was added to the cell suspension at a final concentration of 100 nM and incubated for 30 min at 37 C. The cells were then analyzed by flow cytometry using excitation at 488 nm and emission at 600 nm. A minimum of 10 000 events was collected. Results are presented as single-parameter histograms. The experiment was repeated twice, each time in triplicate. The flow cytometry data were evaluated using WinMDI 2.8 software. Statistical evaluation was assessed on triplicate values for control (untreated) and treatment groups using Student's t-test. The difference in the mean values between control and treatment groups was considered to be statistically significant at the 95% probability level.
Assessment of non-lethal concentrations of inhibitors/antioxidants/Ca
++ modulators Cells were pretreated for 24 h with a range of concentrations (obtained from the literature) of the particular inhibitor, antioxidant or Ca ++ modulating agent to be used in the NF-kB assay. Apoptosis was assessed using brightfield microscopy as described previously (6, (58) (59) (60) . After pretreatment, cells were spun onto glass slides using a Shandon Cytospin 3 centrifuge, fixed in 100% methanol for 3 min and air-dried. Slides were stained for 4 h with modified Giemsa stain (Sigma). One hundred cells were scored for the presence or absence of apoptotic cells. All apoptosis experiments were repeated at least twice. The morphological criteria used for determining the presence of apoptotic cells were condensed chromatin, nuclear fragmentation, cell shrinkage, increased cytoplasmic vacuolization and apoptotic body formation (6, (58) (59) (60) . The highest concentration that did not induce apoptosis (see criteria above) or necrosis (observed as pink-staining swollen cells after staining with Giemsa) was selected for use in the NF-kB assay.
NF-kB activation assay
Cells were seeded at 5 · 10 5 cells/ml in 100 mm tissue culture plates and allowed to attach overnight at 37 C with 5% CO 2 . After 24 h, fresh media with and without inhibitors/antioxidants/Ca ++ modulators (added individually) was added for an additional 24 h. DOC at a concentration of 0.5 mM DOC was added for 4 h. Untreated cells served as the control. Cells were then lysed and the nuclear fractions were collected using the Nuclear Extract kit (Active Motif; Carlsbad, CA) according to the manufacturer's instructions. Briefly, cells were washed with PBS supplemented with phosphatase inhibitors to limit further protein modifications (e.g. dephosphorylation), scraped from the plates and centrifuged for 5 min at 500 r.p.m. at 4 C. The supernatant was removed and the cell pellet was resuspended in hypotonic buffer and incubated on ice. Detergent was added and the solution was briefly vortexed and centrifuged at 14 000· g. The resulting supernatant containing the cytoplasmic fraction was discarded. The nuclear pellet was resuspended in lysis buffer supplemented with DTT and protease inhibitors and incubated on ice. After briefly vortexing, the solution was centrifuged at 14 000· g for 10 min at 4 C. The nuclear fraction supernatant was then stored at À80 C before use. Protein concentration was quantified using the Commassie Plus Assay kit from Pierce Biotechnology (Rockford, Illinois).
The TransAm assays (Active Motif; Carlsbad, CA) for NF-kB activation were performed according the manufacturer's instructions. Briefly, binding buffer was added to wells of an NF-kB-specific, oligonucleotide-coated microtiter plate followed by 2 mg of nuclear extract of each sample diluted in lysis buffer. Each sample was plated in triplicate. The plate was incubated for 1 h on a rocking platform at 100 r.p.m. at room temperature. The plate was washed with washing buffer, and the primary antibody (anti-p50 subunit or anti-p65 subunit), diluted 1 : 1000 in antibody binding buffer, was added for 1 h at room temperature with no agitation. The plate was washed again, and the secondary antibody (1 : 1000 dilution) was added for 1 h. After a final wash step, developing solution was added for 10-20 min at room temperature, and the reaction was terminated with stop solution. The plate was read immediately at 450 nm using a microtiter plate reader.
Statistical evaluation was assessed on triplicate values for control (untreated) and treatment groups using Student's t-test. The difference in the mean values between control and treatment groups was considered to be statistically significant at the 95% probability level. (Figure 1) , the difference between the mean values was not statistically significant.
Results
DOC
A dose-response experiment (DOC concentration versus CMXRos fluorescence) was also performed to determine mitochondrial stress. Treatment of cells with DOC in the concentration range of 0.3-0.5 mM showed a statistically significant decrease in MMP (P < 0.05) compared with control, untreated cells using flow cytometry (Figure 2) . Treatment of cells with DOC in the concentration range of 0.3-0.5 mM showed a statistically significant decrease in MMP (P < 0.05) compared with control, untreated cells using flow cytometry (Figure 2) .
To determine the length of time required to produce the DOC-induced increase in mitochondrial ROS, cells were exposed to 0.5 mM DOC for 1, 2, 3 and 4 h. There was no increase in DOC-induced mitochondrial ROS for the first 3 h of incubation (Figure 3 ). However, there was a marked increase in mitochondrial ROS after 4 h of incubation with 0.5 mM DOC (Figure 3 ).
To demonstrate that DOC induces NF-kB activation at the cellular level, we previously used a monoclonal antibody that recognizes an epitope that spans the nuclear localization signal sequence of the p65 subunit of NF-kB that is normally masked by an inhibitor of NF-kB, IkB (45) . In the present study, we evaluated the ability of the p50 and p65 subunits, comprising the classic NF-kB dimer, to bind to NF-kB oligonucleotide consensus sequences using nuclear lysates (TransAm assays) from HCT-116 cells treated with 0.5 mM DOC for 4 h. DOC-induced p50 and p65 nuclear translocations and binding to DNA, assessed in triplicate, were comparable and reproducible in a total of 20 experiments (10 experiments to assess p50 binding and 10 experiments to assess p65 binding) performed for this study. The mean fold increase of DOC-induced p50 oligonucleotide binding compared with untreated cells was 7.0, with a range of 3.3 to 11.2 in individual experiments. The mean fold increase of DOC-induced p65 oligonucleotide binding compared with untreated cells was 6.0 with a range of 2.9 to 9.8 in individual experiments.
Inhibition of DOC-induced NF-kB activation
A total of 43 different agents that affect various plasma membrane-initiated, organelle-related, Ca ++ -dependent and ROS-dependent signaling pathways were evaluated for ability to affect DOC-induced NF-kB activation. Nuclear translocation of p50 and p65 were evaluated on separate plates using nuclear lysates in triplicate, followed by an antibody against either the p50 or p65 subunit of NF-kB, as described in the Materials and methods section. Only those agents that caused statistically significant changes (P < 0.05) on DOC-induced NF-kB activation and, when used alone, had no effect on constitutive levels of activated NF-kB are shown in Table I . (Note: if constitutive levels of activated NF-kB were altered by a specific agent, the DOC-induced NF-kB activation results would be difficult to interpret). Significant changes based on triplicate assays of either p50 or p65 were used as relevant end points in repeat experiments. There were eight agents that did not, when used alone, affect constitutive NF-kB activation but significantly inhibited DOC-induced NF-kB activation using either p50 or p65 nuclear translocation as the end point. The eight agents ( Table I ) that inhibited DOC-induced NF-kB activation included (i) two natural or dietary-related antioxidants (CAPE and EGCG); (ii) two inhibitors that affect plasma membrane-associated enzymes [one (ouabain) that affects ion transport by Na + /K + -ATPase and another (DPI) that affects the generation of superoxide by NAD(P)H oxidase]; (iii) an inhibitor (TMS) that affects the endoplasmic reticulum (ER) associated enzyme, cytochrome P450; (iv) an inhibitor (NaN 3 ) that affects mitochondrial electron transport; and (v) two agents that inhibit cellular Ca ++ uptake (EGTA and RuR). Of the eight agents that inhibited DOC-induced NF-kB activation, RuR consistently had the greatest effect (>40.0% reduction).
Discussion
Since DOC is a multiple stress inducer (44), it is not surprising that DOC-induced NF-kB activation occurs through multiple mechanisms. In vivo, the persistent activation of NF-kB can lead to inflammation and the development of apoptosis resistance, two conditions that contribute to genomic instability. Thus, chemopreventive strategies that inhibit NF-kB activation should prove beneficial for the prevention of colon cancer.
The mechanisms by which DOC activates NF-kB pathways are diagrammed in Figure 4 . We previously reported that DOC induces NF-kB activation, using a monoclonal antibody that recognizes an epitope that spans the nuclear localization signal sequence of the p65 subunit of NF-kB that is normally masked by an inhibitor of NF-kB, IkB (45) . We also showed that the unmasked p65 subunit translocates to the nucleus, using confocal laser scanning microscopy (45) . This mechanism of NF-kB activation was complemented by the elegant studies of Muhlbauer et al. (61) . These investigators showed that NF-kB activation could be blocked by using MG132, a proteasomal inhibitor, or by preventing IKK activity with a dominant-negative IKKb delivered by adenovirus transfection. The signal-transduction/stress pathways depicted in Figure 4 are based on data obtained in the present study (Figures 1-3 , Table I ) and published data [see Figure 3 of recent review by Bernstein et al. (43) ]. The DOC-induced mediation of NF-kB activation occurs through (i) the generation of oxidative stress; (ii) the activation of plasma membrane-associated proteins; (iii) action of xenobiotic metabolizing enzymes; (iv) mitochondrial perturbation; and (v) the modulation of Ca ++ fluxes. Each of these pathways will be discussed briefly with respect to colon carcinogenesis and the promoting effects of hydrophobic bile acids.
In the present study, we also showed that DOC generates mitochondrial oxidative stress (Figures 1 and 3 ) and reduces MMP (Figure 2) . Mitochondrial perturbation can then result in increased NF-kB activation (present study) and apoptosis resistance (57) . It is probable that high concentrations of the lumenal risk factor, DOC, may promote colon cancer, in part, through an increase in ROS-mediated mitochondrial genomic instability.
Generation of oxidative stress and role of antioxidants in colon carcinogenesis
We have previously shown that lazaroids, inhibitors of lipid peroxidation, prevented DOC-induced NF-kB activation (46) . In the present study, we show that the natural or dietaryrelated antioxidants, CAPE and EGCG, protect against DOCinduced NF-kB activation. CAPE is a phenolic antioxidant derived from the propolis ('bee glue') of honeybee hives (62) and is a known inhibitor of NF-kB (63) . Among all of the green tea phenolic compounds, EGCG is the most bioreactive and represents >50% of the polyphenolic fraction (64) . EGCG has been reported to inhibit NF-kB activation (65) (66) (67) (68) . Here, we report that EGCG inhibits DOC-induced NF-kB activation. This is a potentially new mechanism for the protective effect of EGCG against the tumor-promoting effects of DOC on colon carcinogenesis.
Activation of plasma membrane-associated proteins and role in colon carcinogenesis
The inhibition of NAD(P)H oxidase with DPI and Na + /K + -ATPase with ouabain (Table I) attenuates DOC-induced NF-kB activation. The involvement of these two plasma membrane-associated proteins in DOC-induced NF-kB activation has not been described previously, but is consistent with DOC-induced membrane perturbation at the concentrations used in this study. Since the activation of NAD(P)H oxidase generates superoxide (O 2 À ) (69), this enzyme may be an important source of ROS for the activation of NF-kB. The effect of DOC on the Na + /K + -ATPase may have central importance in colon carcinogenesis. The Na
+ -ATPase is a key regulator of intracellular Na + and K + concentrations (70) . A DOC-induced increase in intracellular K + may be involved in NF-kB activation through the modulation of established or novel kinase pathways (Figure 4) . A high concentration of intracellular K + ions may interfere with multimeric protein assembly as has been shown for the apoptosome (71) . On the other hand, signaling from the Na + /K + -ATPase stimulates the mitochondrial production of ROS (72) that leads to the activation of NF-kB through this mitochondrial-to-cytosol signaling pathway. Since we have shown here that DOC stimulates the production of ROS within mitochondria, the activation of the Na + /K + -ATPase may contribute, in part, to DOC-induced mitochondrial damage.
Xenobiotic metabolizing enzymes and role in colon carcinogenesis
The mechanisms by which cytochrome P450 monooxygenases (CYT450) mediate DOC-induced NF-kB activation are most probably multifactorial. One potential mechanism could be the activation of NF-kB by ROS, since CYT450 represent a significant source of ROS and can damage mitochondria (73, 74) , culminating in massive ROS production from mitochondria (75) . These findings could explain why inhibiting the distal electron transport chain at complex IV with sodium azide (see Table I ) could reduce DOC-induced NF-kB activation through a decrease in respiration, eventually resulting in less total ROS released by the mitochondrial electron transport chain. A second mechanism could involve the metabolism of arachidonic acid (released through DOCinduced phospholipase A 2 activation) to epoxyeicosatrienoic acids (EETs) by cytochrome P450 enzymes (76) . EETs are known to activate voltage-dependent (L-type) Ca ++ channels (76) resulting from the release of Ca ++ from intracellular stores, an increase in cytosolic Ca ++ levels (77) and the activation of NF-kB. Since there are numerous subtypes of CYT450, we cannot determine the exact subtype that contributed to NF-kB activation in the present study. Although the tetramethoxystilbene inhibitor (TMS) used in this study shows specificity for the 1B1 subtype at low nanomolar concentrations in enzyme activity assays, the 5 mM concentration of TMS used to treat the HCT-116 cells may inhibit other subtypes within the intracellular milieu.
Mitochondrial perturbation and colon carcinogenesis ROS released from mitochondria were shown to result in NFkB activation in other cell types (27, 78, 79) . We showed here that inhibition of electron transport using the complex IV inhibitor, NaN 3 , significantly reduced DOC-induced NF-kB activation. We previously reported that DOC induces mitochondrial damage (46, 54, 57) . In the present study, we performed dose-response studies indicating that relatively high pathophysiological concentrations of DOC induce ROS within mitochondria and a loss of MMP. Thus, ROS released from damaged mitochondria with an active electron transport chain is a plausible mechanism for the activation of NF-kB in colon epithelial cells.
Modulation of Ca
++ fluxes and colon carcinogenesis
High cytosolic Ca ++ levels seem to be a major factor in DOC-induced NF-kB activation, since two agents (i.e. EGTA, RuR) used in the present study that affect calcium levels by different mechanisms each had a significant effect on DOC-induced NF-kB activation. EGTA does not cross cell membranes and chelates Ca ++ ions in the extracellular milieu, thereby preventing Ca ++ entry into the cell. RuR is an inorganic polycationic dye that inhibits Ca ++ influx through voltage-sensitive calcium channels (80) and blocks the release of Ca ++ from the ER (81). RuR also acts as an antioxidant through the quenching of ROS (81, 82) . Therefore, the inhibition of DOC-induced NF-kB activation by this agent may occur by RuR binding Ca ++ ions and/or preventing the generation of ROS.
Another mechanism by which increased intracellular Ca ++ levels can lead to the DOC-induced activation of NF-kB is through the activation of the calcium/calmodulin-dependent protein kinase (CaMK). The CaMKs are known to phosphorylate IkB proteins in other cell types (83) (84) (85) (86) and could represent novel targets for chemopreventive strategies.
Conclusions
Understanding the mechanism by which bile acids activate NF-kB, an anti-apoptotic redox-sensitive transcription factor, may be crucial to the prevention of colon carcinogenesis. Our initial findings on DOC-induced NF-kB activation in colon epithelial cells (45, 46) have been confirmed by others using colon epithelial cell lines (61, 87, 88) and primary human colorectal cells challenged ex vivo (61) . In addition, DOC and other relevant bile acids (e.g. taurocholate, taurodeoxycholate, taurochenodeoxycholate, chenodeoxycholate, glycochenodeoxycholate) have been reported to induce NF-kB activation in other cell types of the GI tract (e.g. hepatocytes, esophageal cells, pancreatic acinar cells) (2, (89) (90) (91) (92) (93) (94) (95) (96) (97) . Our findings, therefore, may have global significance for the prevention of GI cancer, in general, by offering targets for reducing bile acid-induced activation of NF-kB.
